Answers are grounded in this paper and cite their sources.
The panel's recommendations are based on currently available evidence considering the most important outcomes in HCM to patients and key stakeholders. Treatment of the primary malignancy is instrumental for controlling hypercalcemia and preventing its recurrence. The recommendations provide a framework for the medical management of adults with HCM and incorporate important decisional and contextual factors. The guidelines underscore current knowledge gaps that can be used to establish future research agendas.
No takes yet. Share an insight, caveat, or question.
Fuleihan et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: